Nurocor Overview
- Founded
- 2017
- Status
- Private
- Employees
- 39
- Latest Deal Type
- Debt
- Investors
- 2
Nurocor General Information
Description
Developer of a digitized clinical development designed to provide assistance in accelerating the clinical development process. The company's platform addresses the metadata challenges facing the BioPharma industry with reduced deployment risk and system downtime, enabling medical research and biopharma companies to improve the quality of medical research and bring new medicines to patients as early as possible.
Contact Information
- 100 Congress Avenue
- Suite 2000
- Austin, TX 78701
- United States
Nurocor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Debt - General | Completed | Generating Revenue | ||||
| 2. Debt - PPP | 27-Apr-2020 | 00000 | Completed | Generating Revenue | ||
| 1. Early Stage VC | 11-May-2017 | Completed | Generating Revenue |
Nurocor Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Barrie Nelson | Chief Standards Officer & Co-Founder | ||
| Alex Lazar | Co-Founder & President |
Nurocor Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Paul Gigg | Self | Chairman | 000 0000 |
Nurocor Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNurocor Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Archer Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Recurring Capital Partners | Lender/Debt Provider | Minority | 000 0000 | 000000 0 |